Gentamicin and Tetracyclines for the Treatment of Human Plague: Review of 75 Cases in New Mexico, 1985–1999

Streptomycin, an antimicrobial with limited availability, is the treatment of choice for plague, a fulminating and potentially epidemic disease that poses a bioterrorism concern. We evaluated the efficacy of gentamicin and tetracyclines for treating human plague. A medical record review was conducte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2004-03, Vol.38 (5), p.663-669
Hauptverfasser: Boulanger, L. Lucy, Ettestad, Paul, Fogarty, John D., Dennis, David T., Romig, Donald, Mertz, Gregory
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 669
container_issue 5
container_start_page 663
container_title Clinical infectious diseases
container_volume 38
creator Boulanger, L. Lucy
Ettestad, Paul
Fogarty, John D.
Dennis, David T.
Romig, Donald
Mertz, Gregory
description Streptomycin, an antimicrobial with limited availability, is the treatment of choice for plague, a fulminating and potentially epidemic disease that poses a bioterrorism concern. We evaluated the efficacy of gentamicin and tetracyclines for treating human plague. A medical record review was conducted on all 75 patients with plague who were reported in New Mexico during 1985-1999. Fifty patients were included in an analysis that compared streptomycin-treated patients (n = 14) with those treated with gentamicin and/or a tetracycline (n = 36). The mean numbers of fever days, hospital days, and complications and the number of deaths did not differ between patients treated with streptomycin and those treated with gentamicin. One patient who received tetracycline alone experienced a serious complication. Gentamicin alone or in combination with a tetracycline was as efficacious as streptomycin for treating human plague. The efficacy of a tetracycline alone could not be determined from the study.
doi_str_mv 10.1086/381545
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_71674803</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4483794</jstor_id><oup_id>10.1086/381545</oup_id><sourcerecordid>4483794</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-b7a25556ba55ba02d68d4a31ca54d60d572dce4d1a7c5b6a2f033312c5776c0f3</originalsourceid><addsrcrecordid>eNqF0c1u1DAQB_AIUdFS4AkQMgc4NWDHHn9wQwvdRSofQououFgTx4G0-VjshLa3vgNvyJPgKqvuCXGyNf_fjCVPlj1i9AWjWr7kmoGAO9kBA65yCYbdTXcKOhea6_3sfoxnlDKmKdzL9pkwWhZAD7Ju6fsRu8Y1PcG-Ims_BnRXrm16H0k9BDL-8GQdPI5dkmSoyWrqsCefWvw--Vfks__V-IubugKywJi60qgPqfTeXzZuOCLMaPhz_ZsZYx5kezW20T_cnofZl-O368UqP_m4fLd4fZI7UbAxLxUWACBLBCiRFpXUlUDOHIKoJK1AFZXzomKoHJQSi5pyzlnhQCnpaM0Ps-fz3E0Yfk4-jrZrovNti70fpmgVk0ro1PQ_yJSimptiB10YYgy-tpvQdBiuLKP2ZgN23kCCT7YTp7Lz1Y5tvzyBZ1uA0WFbB-xdE3cOlBTGyOSezm6YNv9-7PFszuI4hFsl0s6VESnO57iJo7-8jTGcW6m4Ars6_WbfiIU4_boU9pj_BaQkrWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17708392</pqid></control><display><type>article</type><title>Gentamicin and Tetracyclines for the Treatment of Human Plague: Review of 75 Cases in New Mexico, 1985–1999</title><source>MEDLINE</source><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Boulanger, L. Lucy ; Ettestad, Paul ; Fogarty, John D. ; Dennis, David T. ; Romig, Donald ; Mertz, Gregory</creator><creatorcontrib>Boulanger, L. Lucy ; Ettestad, Paul ; Fogarty, John D. ; Dennis, David T. ; Romig, Donald ; Mertz, Gregory</creatorcontrib><description>Streptomycin, an antimicrobial with limited availability, is the treatment of choice for plague, a fulminating and potentially epidemic disease that poses a bioterrorism concern. We evaluated the efficacy of gentamicin and tetracyclines for treating human plague. A medical record review was conducted on all 75 patients with plague who were reported in New Mexico during 1985-1999. Fifty patients were included in an analysis that compared streptomycin-treated patients (n = 14) with those treated with gentamicin and/or a tetracycline (n = 36). The mean numbers of fever days, hospital days, and complications and the number of deaths did not differ between patients treated with streptomycin and those treated with gentamicin. One patient who received tetracycline alone experienced a serious complication. Gentamicin alone or in combination with a tetracycline was as efficacious as streptomycin for treating human plague. The efficacy of a tetracycline alone could not be determined from the study.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/381545</identifier><identifier>PMID: 14986250</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Adult ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimicrobials ; Bacterial diseases ; Biological and medical sciences ; Bioterrorism ; Diseases ; Drug Therapy, Combination - therapeutic use ; Epidemics ; Female ; Fever ; Gentamicins - therapeutic use ; Hospitalization ; Human bacterial diseases ; Humans ; Infectious diseases ; Length of Stay ; Major Articles ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Plague ; Plague - complications ; Plague - drug therapy ; Plague - mortality ; Retrospective Studies ; Septicemic plague ; Streptomycin - therapeutic use ; Sulfonamides ; Tetracyclines - therapeutic use ; Tropical bacterial diseases ; Yersinia pestis - drug effects</subject><ispartof>Clinical infectious diseases, 2004-03, Vol.38 (5), p.663-669</ispartof><rights>Copyright 2004 The Infectious Diseases Society of America</rights><rights>2004 by the Infectious Diseases Society of America 2004</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-b7a25556ba55ba02d68d4a31ca54d60d572dce4d1a7c5b6a2f033312c5776c0f3</citedby><cites>FETCH-LOGICAL-c421t-b7a25556ba55ba02d68d4a31ca54d60d572dce4d1a7c5b6a2f033312c5776c0f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4483794$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4483794$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15764996$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14986250$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boulanger, L. Lucy</creatorcontrib><creatorcontrib>Ettestad, Paul</creatorcontrib><creatorcontrib>Fogarty, John D.</creatorcontrib><creatorcontrib>Dennis, David T.</creatorcontrib><creatorcontrib>Romig, Donald</creatorcontrib><creatorcontrib>Mertz, Gregory</creatorcontrib><title>Gentamicin and Tetracyclines for the Treatment of Human Plague: Review of 75 Cases in New Mexico, 1985–1999</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>Streptomycin, an antimicrobial with limited availability, is the treatment of choice for plague, a fulminating and potentially epidemic disease that poses a bioterrorism concern. We evaluated the efficacy of gentamicin and tetracyclines for treating human plague. A medical record review was conducted on all 75 patients with plague who were reported in New Mexico during 1985-1999. Fifty patients were included in an analysis that compared streptomycin-treated patients (n = 14) with those treated with gentamicin and/or a tetracycline (n = 36). The mean numbers of fever days, hospital days, and complications and the number of deaths did not differ between patients treated with streptomycin and those treated with gentamicin. One patient who received tetracycline alone experienced a serious complication. Gentamicin alone or in combination with a tetracycline was as efficacious as streptomycin for treating human plague. The efficacy of a tetracycline alone could not be determined from the study.</description><subject>Adult</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimicrobials</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>Bioterrorism</subject><subject>Diseases</subject><subject>Drug Therapy, Combination - therapeutic use</subject><subject>Epidemics</subject><subject>Female</subject><subject>Fever</subject><subject>Gentamicins - therapeutic use</subject><subject>Hospitalization</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Length of Stay</subject><subject>Major Articles</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Plague</subject><subject>Plague - complications</subject><subject>Plague - drug therapy</subject><subject>Plague - mortality</subject><subject>Retrospective Studies</subject><subject>Septicemic plague</subject><subject>Streptomycin - therapeutic use</subject><subject>Sulfonamides</subject><subject>Tetracyclines - therapeutic use</subject><subject>Tropical bacterial diseases</subject><subject>Yersinia pestis - drug effects</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0c1u1DAQB_AIUdFS4AkQMgc4NWDHHn9wQwvdRSofQououFgTx4G0-VjshLa3vgNvyJPgKqvuCXGyNf_fjCVPlj1i9AWjWr7kmoGAO9kBA65yCYbdTXcKOhea6_3sfoxnlDKmKdzL9pkwWhZAD7Ju6fsRu8Y1PcG-Ims_BnRXrm16H0k9BDL-8GQdPI5dkmSoyWrqsCefWvw--Vfks__V-IubugKywJi60qgPqfTeXzZuOCLMaPhz_ZsZYx5kezW20T_cnofZl-O368UqP_m4fLd4fZI7UbAxLxUWACBLBCiRFpXUlUDOHIKoJK1AFZXzomKoHJQSi5pyzlnhQCnpaM0Ps-fz3E0Yfk4-jrZrovNti70fpmgVk0ro1PQ_yJSimptiB10YYgy-tpvQdBiuLKP2ZgN23kCCT7YTp7Lz1Y5tvzyBZ1uA0WFbB-xdE3cOlBTGyOSezm6YNv9-7PFszuI4hFsl0s6VESnO57iJo7-8jTGcW6m4Ars6_WbfiIU4_boU9pj_BaQkrWw</recordid><startdate>20040301</startdate><enddate>20040301</enddate><creator>Boulanger, L. Lucy</creator><creator>Ettestad, Paul</creator><creator>Fogarty, John D.</creator><creator>Dennis, David T.</creator><creator>Romig, Donald</creator><creator>Mertz, Gregory</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20040301</creationdate><title>Gentamicin and Tetracyclines for the Treatment of Human Plague: Review of 75 Cases in New Mexico, 1985–1999</title><author>Boulanger, L. Lucy ; Ettestad, Paul ; Fogarty, John D. ; Dennis, David T. ; Romig, Donald ; Mertz, Gregory</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-b7a25556ba55ba02d68d4a31ca54d60d572dce4d1a7c5b6a2f033312c5776c0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimicrobials</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>Bioterrorism</topic><topic>Diseases</topic><topic>Drug Therapy, Combination - therapeutic use</topic><topic>Epidemics</topic><topic>Female</topic><topic>Fever</topic><topic>Gentamicins - therapeutic use</topic><topic>Hospitalization</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Length of Stay</topic><topic>Major Articles</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Plague</topic><topic>Plague - complications</topic><topic>Plague - drug therapy</topic><topic>Plague - mortality</topic><topic>Retrospective Studies</topic><topic>Septicemic plague</topic><topic>Streptomycin - therapeutic use</topic><topic>Sulfonamides</topic><topic>Tetracyclines - therapeutic use</topic><topic>Tropical bacterial diseases</topic><topic>Yersinia pestis - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boulanger, L. Lucy</creatorcontrib><creatorcontrib>Ettestad, Paul</creatorcontrib><creatorcontrib>Fogarty, John D.</creatorcontrib><creatorcontrib>Dennis, David T.</creatorcontrib><creatorcontrib>Romig, Donald</creatorcontrib><creatorcontrib>Mertz, Gregory</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boulanger, L. Lucy</au><au>Ettestad, Paul</au><au>Fogarty, John D.</au><au>Dennis, David T.</au><au>Romig, Donald</au><au>Mertz, Gregory</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gentamicin and Tetracyclines for the Treatment of Human Plague: Review of 75 Cases in New Mexico, 1985–1999</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2004-03-01</date><risdate>2004</risdate><volume>38</volume><issue>5</issue><spage>663</spage><epage>669</epage><pages>663-669</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>Streptomycin, an antimicrobial with limited availability, is the treatment of choice for plague, a fulminating and potentially epidemic disease that poses a bioterrorism concern. We evaluated the efficacy of gentamicin and tetracyclines for treating human plague. A medical record review was conducted on all 75 patients with plague who were reported in New Mexico during 1985-1999. Fifty patients were included in an analysis that compared streptomycin-treated patients (n = 14) with those treated with gentamicin and/or a tetracycline (n = 36). The mean numbers of fever days, hospital days, and complications and the number of deaths did not differ between patients treated with streptomycin and those treated with gentamicin. One patient who received tetracycline alone experienced a serious complication. Gentamicin alone or in combination with a tetracycline was as efficacious as streptomycin for treating human plague. The efficacy of a tetracycline alone could not be determined from the study.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>14986250</pmid><doi>10.1086/381545</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2004-03, Vol.38 (5), p.663-669
issn 1058-4838
1537-6591
language eng
recordid cdi_proquest_miscellaneous_71674803
source MEDLINE; Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals
subjects Adult
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antimicrobials
Bacterial diseases
Biological and medical sciences
Bioterrorism
Diseases
Drug Therapy, Combination - therapeutic use
Epidemics
Female
Fever
Gentamicins - therapeutic use
Hospitalization
Human bacterial diseases
Humans
Infectious diseases
Length of Stay
Major Articles
Male
Medical sciences
Pharmacology. Drug treatments
Plague
Plague - complications
Plague - drug therapy
Plague - mortality
Retrospective Studies
Septicemic plague
Streptomycin - therapeutic use
Sulfonamides
Tetracyclines - therapeutic use
Tropical bacterial diseases
Yersinia pestis - drug effects
title Gentamicin and Tetracyclines for the Treatment of Human Plague: Review of 75 Cases in New Mexico, 1985–1999
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T20%3A20%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gentamicin%20and%20Tetracyclines%20for%20the%20Treatment%20of%20Human%20Plague:%20Review%20of%2075%20Cases%20in%20New%20Mexico,%201985%E2%80%931999&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Boulanger,%20L.%20Lucy&rft.date=2004-03-01&rft.volume=38&rft.issue=5&rft.spage=663&rft.epage=669&rft.pages=663-669&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1086/381545&rft_dat=%3Cjstor_proqu%3E4483794%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17708392&rft_id=info:pmid/14986250&rft_jstor_id=4483794&rft_oup_id=10.1086/381545&rfr_iscdi=true